Monday, January 25, 2021 5:08:31 PM
Of all the charting I do, in this case, the primary indicator I am watching is volume. Average volume is positive and increasing at a nice rate.
The run in June and July 2020 was actually on declining volume, marking a clear top which I confessed to miss in a 2020 post. The lack of support from the company clearly killed investor excitement and is by far the largest complaint from shareholders to date.
I have been noting signals of increased investor interest since November 2020. Low third Q revenue numbers (which I still don't understand)were predicted by at least one of the posters here killed the moment temporarily, but it is clear that investor interest has returned in spite of lack of PR.
I believe the recent increase in interest in $ABMC is helped by the new political regime that is clearly increasing testing. $ABMC is in the perfect place and time to take full advantage of this opportunity, IF they are open to taking advantage of it.
A personal note; The only justification for spending nearly a year here, will be positive fourth quarter revenue numbers or a sharp increase in share price. A change in management and a few PR's would certainly help.
rain
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM